Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment
Clinical trial NCT01949545 · COMPLETED
Trial details
- NCT number
- NCT01949545
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-08-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.